MEMBER-CONTENT

Developing a tool for assessing device design changes to drug delivery devices post-launch

30 May 2024
Developing a tool for assessing device design changes to drug delivery devices post-launch

This presentation available to MediPhorum Drug Delivery members was first presented at Injectable Drug Delivery May 2024 provides insights developed by the Post Launch Change Workstream that will provide comprehensive guidance on FDA change categories and reporting requirements, ensuring compliance towards maintenance of product quality and efficacy.

This document is reserved for the use of MediPhorum members only.

My company would like to become a member

If you would like to enquire on behalf of your company about becoming a member, please see our membership page.

NEWS
What’s your approach to meeting EU MDR Article 117?
NEWS
PFAS – why ECHA proposals could have far-reaching consequences
NEWS
Introducing the new MediPhorum
NEWS
Driving industry consensus on the EU’s Medical Devices regulation
NEWS
Combination products – MediPhorum’s ‘state of the nation’ report